The approval follows results from the DESTINY-Breast06 phase 3 trial, which showed ENHERTU significantly extended progression-free survival compared to chemotherapy
Singlera and Pure Medical will team up with local universities, hospital networks, and national healthcare systems across Western Europe for research studies
The primary goal of the collaboration is joint research into trending and next-generation molecules
The proceeds from the QIP will be used primarily to accelerate the nationwide expansion of the COCO stores of Davaindia nationwide
Tolebrutinib had been provisionally approved in the United Arab Emirates in July 2025 for nrSPMS to slow disability accumulation independent of relapse activity
The approval makes AQVESME the only FDA-approved therapy for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia
Wayrilz represents a new approach to ITP by targeting the disease at its root through multi-immune modulation
Ushio, a leader in advanced optical technologies, brings a strong track record and proprietary Photobonding technology
This production milestone positions Symbiosis at the forefront of meeting rising global demand for life-saving medicines
The opening of our 1000th pharmacy in Karnataka marks an important step
Subscribe To Our Newsletter & Stay Updated
